Home LiteratureArticle Details
PMID: 2185272 Published · ppublish English Journal Article Review

Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.

The Journal of clinical investigation ·Vol. 85 ·No. 5 ·1990-05-00 ·Pages 1343-52

Crystal RG

Abstract

暂无摘要

MeSH Terms
Alleles Base Sequence Codon/genetics Emphysema/blood,genetics,therapy Humans Liver Diseases/blood,genetics,therapy Multigene Family Mutation alpha 1-Antitrypsin/genetics alpha 1-Antitrypsin Deficiency
Chemicals
Codon alpha 1-Antitrypsin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Crystal R G
Pulmonary Branch, National Heart, Lung and Blood Institute, Bethesda, Maryland 20892.
References (37)
37 references, click to expand
  1. Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder.
    J Lab Clin Med. 1969 Jun;73(6):934-9 PMID: 4182334
  2. The alpha 1-antitrypsin gene and its deficiency states.
    Trends Genet. 1989 Dec;5(12):411-7 PMID: 2696185
  3. Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects.
    J Clin Invest. 1981 Nov;68(5):1158-65 PMID: 7028785
  4. Structure and variation of human alpha 1-antitrypsin.
    Nature. 1982 Jul 22;298(5872):329-34 PMID: 7045697
  5. Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function.
    J Mol Biol. 1984 Aug 15;177(3):531-57 PMID: 6332197
  6. Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant.
    Biochemistry. 1984 Oct 9;23(21):4828-37 PMID: 6093867
  7. Synthesis in E. coli of alpha 1-antitrypsin variants of therapeutic potential for emphysema and thrombosis.
    Nature. 1985 Jan 10-18;313(5998):149-51 PMID: 3880873
  8. Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis.
    Am Rev Respir Dis. 1985 Aug;132(2):417-33 PMID: 3896082
  9. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency.
    N Engl J Med. 1986 Mar 20;314(12):736-9 PMID: 3485248
  10. Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals.
    J Clin Invest. 1986 Jun;77(6):1952-61 PMID: 3486887
  11. Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene.
    J Biol Chem. 1986 Dec 5;261(34):15989-94 PMID: 3491072
  12. alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage.
    J Clin Invest. 1986 Dec;78(6):1427-31 PMID: 3537008
  13. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.
    N Engl J Med. 1987 Apr 23;316(17):1055-62 PMID: 3494198
  14. Clonal gene therapy: transplanted mouse fibroblast clones express human alpha 1-antitrypsin gene in vivo.
    Science. 1987 Aug 14;237(4816):762-4 PMID: 3497452
  15. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.
    J Clin Invest. 1987 Nov;80(5):1366-74 PMID: 3500183
  16. Molecular basis of alpha-1-antitrypsin deficiency.
    Am J Med. 1988 Jun 24;84(6A):13-31 PMID: 3289385
  17. Structure, function, and control of neutrophil proteinases.
    Am J Med. 1988 Jun 24;84(6A):37-42 PMID: 2454577
  18. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency.
    Am J Med. 1988 Jun 24;84(6A):52-62 PMID: 3289387
  19. Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency.
    JAMA. 1988 Sep 2;260(9):1259-64 PMID: 3261353
  20. Repair of the secretion defect in the Z form of alpha 1-antitrypsin by addition of a second mutation.
    Science. 1988 Dec 23;242(4886):1700-2 PMID: 2904702
  21. The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy.
    Chest. 1989 Jan;95(1):196-208 PMID: 2642408
  22. Lung function, smoking and survival in severe alpha 1-antitrypsin deficiency, PiZZ.
    J Clin Epidemiol. 1988;41(12):1157-65 PMID: 3264848
  23. Disruption of the 290-342 salt bridge is not responsible for the secretory defect of the PiZ alpha 1-antitrypsin variant.
    J Biol Chem. 1989 Feb 15;264(5):2997-3001 PMID: 2563374
  24. Intracellular traffic of newly synthesized proteins. Current understanding and future prospects.
    J Clin Invest. 1989 Mar;83(3):739-51 PMID: 2646317
  25. Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice.
    J Clin Invest. 1989 Apr;83(4):1183-90 PMID: 2784798
  26. Serum alpha 1-antitrypsin deficiency associated with the common S-type (Glu264----Val) mutation results from intracellular degradation of alpha 1-antitrypsin prior to secretion.
    J Biol Chem. 1989 Jun 25;264(18):10477-86 PMID: 2567291
  27. Interferon beta 2/interleukin 6 modulates synthesis of alpha 1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells.
    J Clin Invest. 1989 Jul;84(1):138-44 PMID: 2472425
  28. Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin.
    Ann Intern Med. 1989 Aug 1;111(3):206-12 PMID: 2787611
  29. Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification.
    J Lab Clin Med. 1989 Aug;114(2):105-13 PMID: 2787825
  30. The molecular pathology of the serpins.
    Mol Biol Med. 1989 Feb;6(1):35-42 PMID: 2666817
  31. Molecular basis of the liver and lung disease associated with the alpha 1-antitrypsin deficiency allele Mmalton.
    J Biol Chem. 1989 Aug 15;264(23):13938-45 PMID: 2788166
  32. Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep.
    J Clin Invest. 1989 Oct;84(4):1145-54 PMID: 2794051
  33. Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency.
    J Clin Invest. 1989 Oct;84(4):1349-54 PMID: 2794066
  34. Synthesis of stress proteins is increased in individuals with homozygous PiZZ alpha 1-antitrypsin deficiency and liver disease.
    J Clin Invest. 1989 Nov;84(5):1555-61 PMID: 2553776
  35. Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia.
    Am J Hum Genet. 1989 Nov;45(5):729-38 PMID: 2683759
  36. Molecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs allele.
    Mol Cell Biol. 1990 Jan;10(1):47-56 PMID: 1967187
  37. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.
    J Clin Invest. 1981 Oct;68(4):889-98 PMID: 6169740
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
DOI
10.1172/JCI114578
Published
1990-05-00
Pages
1343-52
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC296579
Subset
IM
External Links
PubMed source DOI: 10.1172/JCI114578 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2